|1.||Carpentier, André C: 2 articles (11/2012 - 07/2006)|
|2.||Vessby, Bengt: 2 articles (12/2011 - 04/2004)|
|3.||Boman, Kurt: 2 articles (07/2010 - 04/2004)|
|4.||Jansson, Jan-Håkan: 2 articles (07/2010 - 04/2004)|
|5.||Hallmans, Göran: 2 articles (07/2010 - 04/2004)|
|6.||Warensjö, Eva: 2 articles (07/2010 - 04/2004)|
|7.||Nickles, R J: 2 articles (01/2001 - 04/2000)|
|8.||Taylor, M: 2 articles (01/2001 - 04/2000)|
|9.||Stone, C K: 2 articles (01/2001 - 04/2000)|
|10.||Dawczynski, C: 1 article (12/2015)|
01/01/1981 - "Besides confirming our earlier observations, the present study tests the potential of 123I-FFA, hexadecenoic acid (123I-16-ha), and heptadecanoic acid (123I-17-H degree A), in assessing regional myocardial metabolism in 30 patients within a week of proven myocardial infarction. "
01/01/1982 - "In 25 patients with acute myocardial infarction we evaluated regional metabolism with 123 radio-iodinated heptadecanoic acid and segmental 201 thallium scintigraphy in the distribution of the recanalized coronary vessel. "
01/01/1985 - "Twenty-three patients with successful intracoronary thrombolytic therapy in the acute stage of infarction underwent scintigraphy with radioiodinated heptadecanoic acid two weeks after myocardial infarction and three to 12 months later. "
07/01/2010 - "The objective of this study was to investigate the association between the serum milk fat biomarkers pentadecanoic acid (15:0), heptadecanoic acid (17:0), and their sum (15:0+17:0) and a first myocardial infarction (MI). "
04/01/2004 - "The aim of the present study was to prospectively evaluate the potential risk of a first-ever acute myocardial infarction (AMI) in relation to the estimated milk-fat intake, reflected as the proportions of pentadecanoic acid (15 : 0) and heptadecanoic acid (17 : 0) in serum lipid esters. "
11/01/2012 - "Using a recently validated positron emission tomography (PET) imaging method with 14(R,S)-[(¹⁸F]-fluoro-6-thia-heptadecanoic acid to quantify organ-specific dietary fatty acid partitioning, we demonstrate in this study that overweight and obese subjects with impaired glucose tolerance (IGT⁺) display significant increase in fractional myocardial dietary fatty acid uptake over the first 6 h postprandial compared with control individuals (IGT⁻). "
12/01/2011 - "In the current cross-sectional analyses among adolescents (mean age 15 years), we determined whether overweight status modified the associations between dairy fatty acids (pentadecanoic acid (15:0) and heptadecanoic acid (17:0)) represented in serum phospholipids (PL) and markers of inflammation and oxidative stress. "
09/01/2004 - "Trained and untrained healthy male subjects underwent positron emission tomography scanning of the liver and thigh regions, with the FFA analog 14(R,S)-[(18)F]fluoro-6-thia-heptadecanoic acid, during euglycemic hyperinsulinemia. "
07/01/2006 - "The aim of this study was to determine the effect of hyperinsulinemia on myocardial and hepatic distribution and metabolism of 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid ([18F]FTHA). "
|4.||Cardiovascular Diseases (Cardiovascular Disease)
12/01/2015 - "Scrutiny revealed that two of the eight studies included in the meta-analysis focused on the proportion of pentadecanoic acid (C15:0) and heptadecanoic acid (C17:0) and their impact on cardiovascular disease (CVD) risk. "
12/01/2011 - "Pentadecanoic acid (15:0) and heptadecanoic acid (17:0), the dairy-specific saturated fatty acids have been inversely, while inflammation and oxidative stress have been positively related to the risk of cardiovascular disease (CVD). "
01/01/2001 - "In this study, we investigated the kinetics of 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid (FTHA) and [18F]FDG in patients with stable New York Heart Association functional class III congestive heart failure and a left ventricular ejection fraction of no more than 35%. "
01/01/2001 - "An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure."
|4.||Biological Markers (Surrogate Marker)
|7.||Linoleic Acid (Linoleate)
|8.||Oleic Acid (Oleate)